Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-059300
Filing Date
2025-04-28
Accepted
2025-04-28 16:09:58
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-28

Document Format Files

Seq Description Document Type Size
1 ARS 2025_ars_10k.pdf ARS 489355
  Complete submission text file 0000950170-25-059300.txt   675523
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 033-80623 | Film No.: 25880404
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)